News & Updates

Show Multimedia Only

Several factors must be considered when tapering adalimumab in noninfectious uveitis patients

24 Sep 2023

For patients who undergo adalimumab tapering after achieving remission, factors such as age, race, and duration of disease remission on adalimumab appear to impact the risk of relapse, according to a study.

Several factors must be considered when tapering adalimumab in noninfectious uveitis patients

24 Sep 2023

Common antihypertensive drug linked to glaucoma

15 Sep 2023 by

The use of calcium channel blockers (CCBs) may contribute to an increased risk of glaucoma despite CCBs having no effect on intraocular pressure (IOP), according to a large study.

Common antihypertensive drug linked to glaucoma

15 Sep 2023

Smoking tied to severe, frequent ocular symptoms in young people

11 Sep 2023

Among teens and young adults, users of both e-cigarettes and cigarettes are more likely to experience severe and frequent ocular symptoms than abstainers, as reported in a study.

Smoking tied to severe, frequent ocular symptoms in young people

11 Sep 2023

Can retinal thinning predict disability in MS?

07 Sep 2023 by

Retinal thinning predicts disability in patients newly diagnosed with relapsing multiple sclerosis (MS), an immune-mediated disease affecting the brain and spinal cord, in a new study presented at EAN 2023.

Can retinal thinning predict disability in MS?

07 Sep 2023

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

01 Sep 2023

Treatment with brolucizumab results in a longer interval between injections of antivascular endothelial growth factor (anti-VEGF) agents for most treatment-experienced eyes, especially those with shorter intervals before switching, while maintaining or improving visual acuity (VA), reports a study.

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

01 Sep 2023

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

01 Sep 2023 by

Treatment with dexamethasone implant results in better outcomes for patients with persistent or recurrent uveitic macular edema (ME) at 12 weeks when compared with methotrexate or ranibizumab, a study has shown. The risk of intraocular pressure (IOP), however, is higher with dexamethasone, but elevations to levels of 30 mm Hg or more are rare.

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

01 Sep 2023

Original New Drug Application Approvals by US FDA (16-31 August 2023)

01 Sep 2023

New drug applications approved by US FDA as of 16-31 August 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 August 2023)

01 Sep 2023

What is the leading cause of blindness in children?

31 Aug 2023

Retinopathy of prematurity (ROP) appears to be the leading cause of childhood blindness, reveals a recent study in the US. More than half of these blind patients have had a treatable cause of blindness.

What is the leading cause of blindness in children?

31 Aug 2023

Virtual classes linked to increased myopia risk among children

21 Aug 2023 by

Children’s eye health is essential for the normal maturation process of their visual system.

Virtual classes linked to increased myopia risk among children

21 Aug 2023

Eye drops for myopia control in kids disappoint in US study

07 Aug 2023 by

Nightly administration of atropine 0.01% eye drops does little to slow myopia progression or axial elongation in a cohort of school-aged children in the US who have low-to-moderate myopia, as shown in a study.

Eye drops for myopia control in kids disappoint in US study

07 Aug 2023

News & Updates

Filter by Specialty:

Specialty:

Several factors must be considered when tapering adalimumab in noninfectious uveitis patients

Several factors must be considered when tapering adalimumab in noninfectious uveitis patients

Common antihypertensive drug linked to glaucoma

Common antihypertensive drug linked to glaucoma

Smoking tied to severe, frequent ocular symptoms in young people

Smoking tied to severe, frequent ocular symptoms in young people

Can retinal thinning predict disability in MS?

Can retinal thinning predict disability in MS?

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

Original New Drug Application Approvals by US FDA (16-31 August 2023)

Original New Drug Application Approvals by US FDA (16-31 August 2023)

What is the leading cause of blindness in children?

What is the leading cause of blindness in children?

Virtual classes linked to increased myopia risk among children

Virtual classes linked to increased myopia risk among children

Eye drops for myopia control in kids disappoint in US study

Eye drops for myopia control in kids disappoint in US study